Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Origin Bancorp, Inc. Reports Earnings for First Quarter 2024
-
Univest Financial Corporation Reports First Quarter Results
-
Northrim BanCorp Earns $8.2 Million, or $1.48 Per Diluted Share, in First Quarter 2024
-
Comstock Extends Existing Promissory Notes Through April 2026
-
Origin Bancorp, Inc. Announces Declaration of Quarterly Cash Dividend
-
FreightCar America, Inc. To Release First Quarter Results On May 8, 2024
-
FreightCar America, Inc. to Present at Planet MicroCap Showcase: VEGAS 2024
-
ARMOUR Residential REIT, Inc. First Quarter 2024 Webcast Scheduled for April 26, 2024
-
Wearable Devices Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement
-
Plexus Announces Fiscal Second Quarter Financial Results
-
Matthews International Declares Quarterly Dividend
-
Sports ETA releases its 2023 “State of the Industry” Report for the $128 Billion Sport Tourism Industry
-
Raymond James Financial Reports Fiscal Second Quarter of 2024 Results
-
Goosehead Insurance, Inc. Announces First Quarter 2024 Results
-
National Bank Holdings Corporation Announces First Quarter 2024 Financial Results
-
John B. Sanfilippo & Son, Inc. 3rd Quarter Fiscal Year 2024 Operating Results Conference Call
-
John B. Sanfilippo & Son, Inc. 3rd Quarter Fiscal Year 2024 Operating Results Conference Call
-
ContextLogic to Announce First Quarter 2024 Results on May 8, 2024
-
TScan Therapeutics Announces Upcoming Presentations at the 2024 American Society of Clinical Oncology Annual Meeting
-
Supernus Pharmaceuticals to Announce First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024
-
NextNav Announces Date for First Quarter 2024 Earnings Call
-
Orion Group Holdings Reports First Quarter 2024 Results
-
Brookline Bancorp Announces First Quarter Results
-
TScan Therapeutics Announces Upcoming Presentations at the 2024 American Society of Clinical Oncology Annual Meeting
-
JAKKS Pacific Reports First Quarter 2024 Financial Results
-
Elutia to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1
-
Horizon Bancorp, Inc. Reports Solid First Quarter 2024 Results Including EPS of $0.32, Net Interest Margin Expansion, Loan Growth and Well-Managed Operating Expenses
-
Cidara Therapeutics Reacquires Global Development and Commercial Rights to CD388 and Announces Private Placement Financing of $240 Million
-
Covenant Logistics Group Announces First Quarter Financial and Operating Results
-
Leslie’s, Inc. to Report Second Quarter Fiscal 2024 Financial Results on May 8, 2024
-
Dave & Buster’s Appoints New Chief Financial Officer
-
Eagle Bancorp, Inc. Announces Results of Operations for First Quarter 2024
-
Corbus Pharmaceuticals Announces Abstract Accepted for Presentation at 2024 ASCO Annual Meeting
-
Sensei Biotherapeutics to Present Topline Clinical Data from the SNS-101 Phase I Dose Escalation Study at the 2024 ASCO Annual Meeting
-
Erasca Announces Three Presentations at the 2024 ASCO Annual Meeting
-
ClearPoint Neuro Announces Initiation of Limited Market Release for the SmartFrame OR™ Stereotactic System
-
Nasdaq Announces Mid-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date April 15, 2024
-
FNCB Bancorp, Inc. Declares Second Quarter 2024 Dividend
-
Mama’s Creations Reports Fourth Quarter and Fiscal Year 2024 Financial Results
-
Ethan Allen Reports Fiscal 2024 Third Quarter Results Highlighted by Robust Balance Sheet, Strong Cash Dividends and Double-Digit Operating Margin; Lower Demand Reflects Post Pandemic Period
-
Venus Concept Announces Loan Purchase and Completion of First Phase of Refinancing
-
Black Diamond Therapeutics Announces Presentations at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
-
Fossil Group, Inc. Announces Date for First Quarter 2024 Earnings Release and Conference Call
-
Cardlytics Announces Timing of Its First Quarter 2024 Earnings Release
-
Predictive Oncology Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
-
Beyond Meat® to Report First Quarter 2024 Financial Results on May 8, 2024
-
23andMe to Present Preliminary Efficacy and Biomarker Data for 23ME-00610 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
-
Appian To Announce First Quarter 2024 Financial Results on May 2
-
ZimVie to Report First Quarter Financial Results on May 8, 2024
-
Safe Bulkers, Inc. Sets Date for the First Quarter 2024 Results, Conference Call, and Webcast

